215 related articles for article (PubMed ID: 23809192)
1. Vitamin D, parathyroid hormone and muscle impairment in myotonic dystrophies.
Passeri E; Bugiardini E; Sansone VA; Valaperta R; Costa E; Ambrosi B; Meola G; Corbetta S
J Neurol Sci; 2013 Aug; 331(1-2):132-5. PubMed ID: 23809192
[TBL] [Abstract][Full Text] [Related]
2. Dysregulation of calcium metabolism in type 1 myotonic dystrophy.
Hlaing PM; Scott IA; Jackson RV
Intern Med J; 2019 Nov; 49(11):1412-1417. PubMed ID: 30963668
[TBL] [Abstract][Full Text] [Related]
3. Increases in parathyroid hormone (PTH) after gastric bypass surgery appear to be of a secondary nature.
Jin J; Robinson AV; Hallowell PT; Jasper JJ; Stellato TA; Wilhem SM
Surgery; 2007 Dec; 142(6):914-20; discussion 914-20. PubMed ID: 18063076
[TBL] [Abstract][Full Text] [Related]
4. Vitamin D deficiency in myotonic dystrophy type 1.
Terracciano C; Rastelli E; Morello M; Celi M; Bucci E; Antonini G; Porzio O; Tarantino U; Zenobi R; Massa R
J Neurol; 2013 Sep; 260(9):2330-4. PubMed ID: 23754696
[TBL] [Abstract][Full Text] [Related]
5. Plasma 25-hydroxyvitamin D and not 1,25-dihydroxyvitamin D is associated with parathyroid adenoma secretion in primary hyperparathyroidism: a cross-sectional study.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Eur J Endocrinol; 2006 Aug; 155(2):237-44. PubMed ID: 16868136
[TBL] [Abstract][Full Text] [Related]
6. Renal function and 25-hydroxyvitamin D concentrations predict parathyroid hormone levels in renal transplant patients.
Boudville NC; Hodsman AB
Nephrol Dial Transplant; 2006 Sep; 21(9):2621-4. PubMed ID: 16644777
[TBL] [Abstract][Full Text] [Related]
7. Vitamin D status, seasonal variations, parathyroid adenoma weight and bone mineral density in primary hyperparathyroidism.
Moosgaard B; Vestergaard P; Heickendorff L; Melsen F; Christiansen P; Mosekilde L
Clin Endocrinol (Oxf); 2005 Nov; 63(5):506-13. PubMed ID: 16268801
[TBL] [Abstract][Full Text] [Related]
8. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
9. Are low plasma levels of 25-(OH)vitamin D a major risk factor for hyperparathyroidism independent of calcitriol in renal transplant patients?
Lomonte C; Antonelli M; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Verrelli EA; Basile C
J Nephrol; 2005; 18(1):96-101. PubMed ID: 15772930
[TBL] [Abstract][Full Text] [Related]
10. Parathyroid hormone, vitamin D, renal dysfunction, and cardiovascular disease: dependent or independent risk factors?
Anderson JL; Vanwoerkom RC; Horne BD; Bair TL; May HT; Lappé DL; Muhlestein JB
Am Heart J; 2011 Aug; 162(2):331-339.e2. PubMed ID: 21835295
[TBL] [Abstract][Full Text] [Related]
11. Hyperparathyroidism and vitamin D deficiency after laparoscopic gastric bypass.
Clements RH; Yellumahanthi K; Wesley M; Ballem N; Bland KI
Am Surg; 2008 Jun; 74(6):469-474; discussion 474-5. PubMed ID: 18556987
[TBL] [Abstract][Full Text] [Related]
12. Muscle pathology in myotonic dystrophy: light and electron microscopic investigation in eighteen patients.
Nadaj-Pakleza A; Lusakowska A; Sułek-Piątkowska A; Krysa W; Rajkiewicz M; Kwieciński H; Kamińska A
Folia Morphol (Warsz); 2011 May; 70(2):121-9. PubMed ID: 21630234
[TBL] [Abstract][Full Text] [Related]
13. Cutaneous features of myotonic dystrophy types 1 and 2: Implication of premature aging and vitamin D homeostasis.
Campione E; Botta A; Di Prete M; Rastelli E; Gibellini M; Petrucci A; Bernardini S; Novelli G; Bianchi L; Orlandi A; Massa R; Terracciano C
Neuromuscul Disord; 2017 Feb; 27(2):163-169. PubMed ID: 28065683
[TBL] [Abstract][Full Text] [Related]
14. [Prevalence of secondary hyperparathyroidism (SHPT) and causal factors in adult population in Reykjavík area].
Karlsson SL; Indridason OS; Franzson L; Sigurdsson G
Laeknabladid; 2005 Feb; 91(2):161-9. PubMed ID: 16155312
[TBL] [Abstract][Full Text] [Related]
15. Effect of vitamin D nutrition on parathyroid adenoma weight: pathogenetic and clinical implications.
Rao DS; Honasoge M; Divine GW; Phillips ER; Lee MW; Ansari MR; Talpos GB; Parfitt AM
J Clin Endocrinol Metab; 2000 Mar; 85(3):1054-8. PubMed ID: 10720039
[TBL] [Abstract][Full Text] [Related]
16. [Bone metabolism in patients with newly diagnosed caeliac disease].
Deressa E; Wammer AC; Falch JA; Jahnsen J
Tidsskr Nor Laegeforen; 2006 Apr; 126(9):1201-4. PubMed ID: 16670741
[TBL] [Abstract][Full Text] [Related]
17. Failure to normalize parathyroid hormone during treatment of vitamin D deficiency in Asian patients.
Peacey SR; Wright D; Harries MJ
Clin Endocrinol (Oxf); 2004 Nov; 61(5):603-6. PubMed ID: 15521963
[TBL] [Abstract][Full Text] [Related]
18. Prevalence of vitamin D deficiency and secondary hyperparathyroidism during winter in pre-menopausal Bangladeshi and Somali immigrant and ethnic Finnish women: associations with forearm bone mineral density.
Islam MZ; Viljakainen HT; Kärkkäinen MU; Saarnio E; Laitinen K; Lamberg-Allardt C
Br J Nutr; 2012 Jan; 107(2):277-83. PubMed ID: 21824446
[TBL] [Abstract][Full Text] [Related]
19. Impact of ergocalciferol treatment of vitamin D deficiency on serum parathyroid hormone concentrations in chronic kidney disease.
Zisman AL; Hristova M; Ho LT; Sprague SM
Am J Nephrol; 2007; 27(1):36-43. PubMed ID: 17215573
[TBL] [Abstract][Full Text] [Related]
20. Serum NT-proBNP Levels Are Not Related to Vitamin D Status in Young Patients with Congenital Heart Defects.
Passeri E; Rigolini R; Costa E; Verdelli C; Arcidiacono C; Carminati M; Corbetta S
Dis Markers; 2016; 2016():3970284. PubMed ID: 26955207
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
